Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo

NCT01734824 · clinicaltrials.gov ↗

PHASE4

Phase

SUSPENDED

Status

90

Enrollment

OTHER

Sponsor class

Stopped no patients randomized

Conditions

Bone Marrow Oedema Syndrome
High Turnover Bone Disease
Quality of Life

Interventions

DRUG: Denosumab
DRUG: Teriparatide
DRUG: Placebo Denosumab
DRUG: Placebo Teriparatide

Sponsor

Medical University of Vienna